Available Technologies

The UNT Health Science Center is actively seeking to develop and commercialized technologies through collaborative research and licensing relationships. The following Biomedical Technologies and Research Tools are available for licensing and sponsored research partnerships:
Case Technology Faculty Inventors Patent Status
2013-017 Radiotherapeutic Bandage Containing Holmium-166 Nanoparticles for Treatment of Skin Cancer Anthony J. Di Pasqua US Patent Pending pdf
2013-017a Platinum Drug Loaded Holmium and Dysprosium Containing Garnet Nanoparticles for Cancer Radiotherapy and Chemotherapy Anthony J. Di Pasqua US Patent Pending pdf
2010-008 Compounds that Enable Alternative Mitochondrial
Electron Transfer
James W. Simpkins,
Shaohua Yang
US Patent Pending pdf
2010-007 Polarized Fluorescent Nanospheres Zygmunt Gryczynski
Ignancy Gryczynski
Julian Borejdo
Published as
US 20110207614
pdf
2009-100 Compound to Discriminate Serotonin Receptor Subtype John Schetz pdf
2009-009 Polarization Standards for Confocal Microscopy Zygmunt Gryczynski
Ignancy Gryczynski
Julian Borejdo
Published as
US 20110207614
pdf
2008-007 Anti-Infective Compounds that Inhibit Growth of MRSA John Schetz Published as
US 20110301078
pdf
2008-003 Fluorescent Microscope & Method for Detecting Surface and Intracellular Phenomena Zygmunt Gryczynski
Ignancy Gryczynski
Julian Borejdo
US Patent 7,956,989
US Patent 8,159,676
pdf
2007-108 Cell Line for Unambiguous Screening of Sigma1 Receptor Ligands John Schetz pdf
2007-105 Polyclonal Antibodies against Recombinant Lecithin-Cholesterol Acyltransferase (LCAT) Andras Lacko
Walter McConathy
pdf
2007-104 Polyclonal Antibodies against Human Serum Apolipoproteins Andras Lacko
Walter McConathy
pdf
2007-103 Recombinant Lecithin-Cholesterol Acyltransferase (LCAT) Andras Lacko
Walter McConathy
pdf
2007-010 Activated Polymeric Nanoparticles for Targeted Drug Delivery in Cancer Therapy Jamboor Vishwanatha US Patent 9,023,395 pdf
2005-014 Antitumor Modulator for Enhancement of Chemotherapeutic Agents in Cancer Therapy Wolfram Siede Published as
US 20080085882
Description: pdf
2005-011 Green Additives for Controlling Zebra Mussel Fouling John Schetz US Patent 8,575,230 pdf
2003-070 Selective Dopamine D3 Receptor Ligands Robert Luedtke US Patent 7,605,259
US Patent 8,119,642
Description: pdf
2000-031 Monoclonal Antibody Against CS1 Receptor for Cancer Therapy Porunelloor Mathew US Patent 7,041,499 Description: pdf
2000-100 Monoclonal Antibody against CS1 Receptor Porunelloor Mathew US Patent 7,041,499 Description: pdf
1995-100 Monoclonal Antibodies against Dopamine Receptor Subtypes D1a & D1b Robert Luedtke pdf
For additional information or inquiries about sponsored research or licensing opportunities, please contact our office at (817) 735-5147.